Specialty injectable drug development
MAIA's strategy includes internal development of specialty injectable drugs.
Source: LinkedIn company description · Retrieved October 13, 2026
MAIA Pharmaceuticals is a U.S.-based specialty pharmaceutical company focused on acquiring, developing, and commercializing products for hospital, outpatient, and specialty settings.
MAIA is headquartered in Princeton, New Jersey, USA, and has a revenue-generating platform supported by supply chain partnerships, regulatory expertise, and a commercialization strategy. Its current portfolio includes FDA-approved injectable and specialty products distributed nationwide through hospital and specialty channels.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
MAIA's strategy includes internal development of specialty injectable drugs.
Source: LinkedIn company description · Retrieved October 13, 2026
MAIA's strategy includes targeted in-licensing of late-stage or approved assets.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 4, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 16, 2026, September 28, 2026 and October 7, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.